跳至主導覽 跳至搜尋 跳過主要內容

The role of Asprosin in patients with dilated cardiomyopathy

  • Ming Shien Wen*
  • , Chao Yung Wang*
  • , Jih Kai Yeh
  • , Chun Chi Chen
  • , Ming Lung Tsai
  • , Ming Yun Ho
  • , Kuo Chun Hung
  • , I. Chang Hsieh
  • *此作品的通信作者
  • Chang Gung University
  • National Health Research Institutes Taiwan

研究成果: 期刊稿件 › 文章 › 同儕審查

57 引文 斯高帕斯(Scopus)

摘要

Background: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therapeutic target in heart failure treatment. We hypothesized that the asprosin is able to modulate cardiac mitochondrial functions and has important prognostic implications in dilated cardiomyopathy (DCM) patients. Methods: We prospectively enrolled 50 patients (86% male, mean age 55 ± 13 years) with DCM and followed their 5-year major adverse cardiovascular events from 2012 to 2017. Comparing with healthy individuals, DCM patients had higher asprosin levels (191.2 versus 79.7 ng/mL, P < 0.01). Results: During the 5-year follow-up in the study cohort, 16 (32.0%) patients experienced adverse cardiovascular events. Patients with lower asprosin levels (< 210 ng/mL) were associated with increased risks of adverse clinical outcomes with a hazard ratio of 7.94 (95% CI 1.88-33.50, P = 0.005) when compared patients with higher asprosin levels (≥ 210 ng/mL). Using cardiomyoblasts as a cellular model, we showed that asprosin prevented hypoxia-induced cell death and enhanced mitochondrial respiration and proton leak under hypoxia. Conclusions: In patients with DCM, elevated plasma asprosin levels are associated with less adverse cardiovascular events in five years. The underlying protective mechanisms of asprosin may be linked to its functions relating to enhanced mitochondrial respiration under hypoxia.

原文英語
文章編號402
期刊BMC Cardiovascular Disorders
卷20
發行號1
DOIs
出版品狀態已出版 - 07 09 2020

文獻附註

Publisher Copyright:
© 2020 The Author(s).

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「The role of Asprosin in patients with dilated cardiomyopathy」主題。共同形成了獨特的指紋。

引用此